Volume 10 Issue 3
May  2019
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2019  >  10(3): 313-317
Wang Bo, Li Xiao, Zhang Pengcheng, et al. Effect of hypernatremia in donors on perioperative liver function of recipients undergoing liver transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(3): 313-317. doi: 10.3969/j.issn.1674-7445.2019.03.015
Citation: Wang Bo, Li Xiao, Zhang Pengcheng, et al. Effect of hypernatremia in donors on perioperative liver function of recipients undergoing liver transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(3): 313-317. doi: 10.3969/j.issn.1674-7445.2019.03.015
shu

Effect of hypernatremia in donors on perioperative liver function of recipients undergoing liver transplantation

doi: 10.3969/j.issn.1674-7445.2019.03.015

  • Department of Hepatobiliary Surgery, Xijing Hospital of Air Force Medical University, Xi 'an 710032, China

More Information
  • Corresponding author: Tao Kaishan, Email: taokaishan0686@163.com
  • Received Date: 2019-03-02
    Available Online: 2021-01-19
  • Publish Date: 2019-05-15
    Abstract
  •   Objective  To evaluate the effect of hypernatremia in donors on perioperative recovery of liver function in the recipients undergoing liver transplantation.  Methods  Clinical data of 73 liver transplant recipients were analyzed retrospectively. According to the serum levels of sodium in donors, all recipients were divided into hypernatremia group (donor serum sodium ≥150 mmol/L, n=19) and non-hypernatremia group (donor serum sodium < 150 mmol/L, n=54). Serum alanine aminotransferase(ALT), aspartate aminotransferase (AST), model for end-stage liver disease (MELD) score, albumin, total bilirubin (TB), serum creatinine, prothrombin time and hepatocyte growth factor (HGF) in the recipients were detected at 1, 3, 7, 14 and 21 d after liver transplantation. The time of postoperative use of liver-protecting drugs in the recipients, the length of intensive care unit (ICU) stay, the average length of hospital stay and the incidence rate of postoperative complications were statistically compared and analyzed.  Results  Compared with the non-hypernatremia group, the serum levels of TB, ALT, AST, HGF and MELD scores of the recipients in the hypernatremia group at the postoperative 1, 3 and 7 d were significantly higher (all P < 0.05), whereas the serum albumin level was significantly decreased (P < 0.05). The prothrombin time in the hypernatremia group was significantly longer than that in the non-hypernatremia group at 3 and 7 d after operation (both P < 0.05). In the hypernatremia group, the time of postoperative use of liver-protecting drugs and the length of ICU stay were 9 (7-13) d and 11 (8-13) d, significantly longer than 4 (3-9) d and 7 (3-9) d in the non-hypernatremia group (both P < 0.05). The average length of hospital stay, serum creatinine level and incidence rate of postoperative complications did not significantly differ between two groups (all P>0.05). All recipients were recovered and discharged.  Conclusions  The hypernatremia in donors exert no significant effect on the perioperative liver function of the recipients, whereas it can prolong the postoperative recovery time of liver function of the recipients.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    NEMES B, GÁMÁN G, POLAK WG, et al. Extended criteria donors in liver transplantation part Ⅰ: reviewing the impact of determining factors[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(7):827-839. DOI: 10.1586/17474124.2016.1149061.
    [2]
    NEMES B, GÁMÁN G, POLAK WG, et al. Extended-criteria donors in liver transplantation part Ⅱ: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(7):841-859. DOI: 10.1586/17474124.2016.1149062.
    [3]
    BENKO T, GALLINAT A, MINOR T, et al. The postoperative model for end stage liver disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers[J]. Eur J Gastroenterol Hepatol, 2017, 29(6):716-722. DOI: 10.1097/MEG.0000000000000851.
    [4]
    KNAAK M, GOLDARACENA N, DOYLE A, et al. Donor BMI > 30 is not a contraindication for live liver donation[J]. Am J Transplant, 2017, 17(3):754-760. DOI: 10.1111/ajt.14019.
    [5]
    MAZAHERI M, MOJTABAEE M, MOHSENZADEH M, et al. Liver donation from marginal donors: to donate or not to donate? [J]. Exp Clin Transplant, 2019, 17(Suppl 1):254-256. DOI: 10.6002/ect.MESOT2018.P112.
    [6]
    SAIDI RF. Utilization of expanded criteria donors in liver transplantation[J]. Int J Organ Transplant Med, 2013, 4(2):46-59. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_51eba3906b025a150d904fb7e2555d28
    [7]
    LOZANOVSKI VJ, KHAJEH E, FONOUNI H, et al. The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation[J]. Langenbecks Arch Surg, 2018, 403(6):719-731. DOI: 10.1007/s00423-018-1704-z.
    [8]
    FRANZINI M, GHINOLFI D, PEZZATI D, et al. Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers[J]. Liver Transpl, 2016, 22(11):1615-1616. DOI: 10.1002/lt.24601.
    [9]
    BURLAGE LC, KARIMIAN N, WESTERKAMP AC, et al. Oxygenated hypothermic machine perfusion after static cold storage improves endothelial function of extended criteria donor livers[J]. HPB (Oxford), 2017, 19(6):538-546. DOI: 10.1016/j.hpb.2017.02.439.
    [10]
    ROUTH D, SHARMA S, NAIDU CS, et al. Comparison of outcomes in ideal donor and extended criteria donor in deceased donor liver transplant: a prospective study[J]. Int J Surg, 2014, 12(8):774-777. DOI: 10.1016/j.ijsu.2014.06.003.
    [11]
    PARK GC, SONG GW, MOON DB, et al. A review of current status of living donor liver transplantation[J]. Hepatobiliary Surg Nutr, 2016, 5(2):107-117. DOI: 10.3978/j.issn.2304-3881.2015.08.04.
    [12]
    GUARRERA JV, HENRY SD, SAMSTEIN B, et al. Hypothermic machine preservation facilitates successful transplantation of " orphan" extended criteria donor livers[J]. Am J Transplant, 2015, 15(1):161-169. DOI: 10.1111/ajt.12958.
    [13]
    JADLOWIEC CC, TANER T. Liver transplantation: current status and challenges[J]. World J Gastroenterol, 2016, 22(18):4438-4445. DOI: 10.3748/wjg.v22.i18.4438.
    [14]
    VODKIN I, KUO A. Extended criteria donors in liver transplantation[J]. Clin Liver Dis, 2017, 21(2):289-301. DOI: 10.1016/j.cld.2016.12.004.
    [15]
    DIRICAN A, OZSOY M, ATES M, et al. Consequences of the use of extended criteria donors in living donor liver transplantation[J]. Ann Transplant, 2015, 20:211-217. DOI: 10.12659/AOT.892454.
    [16]
    KASEJE N, MCLIN V, TOSO C, et al. Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation[J]. Liver Transpl, 2015, 21(8):1076-1081. DOI: 10.1002/lt.24145.
    [17]
    FOGUET C, MARIN S, SELIVANOV VA, et al. HepatoDyn: a dynamic model of hepatocyte metabolism that integrates 13C isotopomer data[J]. PLoS Comput Biol, 2016, 12(4):e1004899. DOI: 10.1371/journal.pcbi.1004899.
    [18]
    SAHI J, GREPPER S, SMITH C. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery[J]. Curr Drug Discov Technol, 2010, 7(3):188-198. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=7b74305473f6fa1bfd8b6ce3ec25b736
    [19]
    BIFULCO M, PISANTI S, CIAGLIA E. The complex interplay among hepatocytes and immune cells at the crossroad between inflammation and cholesterol metabolism in hyperglycemia[J]. Endocrine, 2017, 58(1):21-23. DOI: 10.1007/s12020-017-1254-0.
    [20]
    YUAN X, HUANG H, HUANG Y, et al. Nuclear factor E2-related factor 2 knockdown enhances glucose uptake and alters glucose metabolism in AML12 hepatocytes[J]. Exp Biol Med (Maywood), 2017, 242(9):930-938. DOI: 10.1177/1535370217694435.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (287) PDF downloads(17) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return